[Answered] Carter and Hesse-Biber argue that gender roles are powerful and coercive. a. true b. ...

This topic contains a solution. Click here to go to the answer

Author Question: Carter and Hesse-Biber argue that gender roles are powerful and coercive. a. true b. ... (Read 59 times)

V@ndy87

Hero Member
Posts: 571

on: Jul 2, 2018

Carter and Hesse-Biber argue that gender roles are powerful and coercive.

a. true
b. false

Question 2

Ethnic group membership ___________________ ___________________ __.

a. partly determines how others treat you
b. raises false consciousness
c. influences your chances for economic success
d. reduces economic inequality
e. a & c

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

livaneabi

Sr. Member
Posts: 328

Reply #1 on: Jul 2, 2018

Answer to Question 1

a

Answer to Question 2

e

V@ndy87

Member
Posts: 571

Reply 2 on: Jul 2, 2018

Thanks for the timely response, appreciate it

vickyvicksss

Member
Posts: 351

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.